Brainscape's Knowledge GenomeTM

Browse over 1 million classes created by top students, professors, publishers, and experts.


See full index

Lab 2 > Oromucosal administration > Flashcards

Oromucosal administration Flashcards

1
Q

Describe how drugs are absorbed through the oral mucosa

Discuss how drug properties can affect drug transport

Discuss the impact of the type of dosage form on bioavailability

Describe and discuss common pharmaceutical dosage forms used for oro-buccal delivery (local and systemic)

A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Give examples of mucosal delivery sites (7)?

A
  • oral
  • nasal
  • intestinal for swallowed dosage forms
  • vaginal
  • pulmonary
  • rectal
  • ocular
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

which oral mucosa is keratinised and purpose?

A

masticatory - protect against mechanical trauma from chewing

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

what oral mucosa is targeted for drug admin and why?

A

lining mucosa: non-keratinised

less barrier to drug absorption compared to keratinised

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

lining of the oral cavity, what 3 types of stratified squamous epithelium are there?

A
  • mastciatory mucosa
  • lining mucosa
  • specialised mucosa: taste buds
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

what 3 main glands produce saliva and how much?

A
  • sublingual
  • parotid ++ (close to ears)
  • submandibular ++++ (lower jaw)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

what is saliva composed of?

A

an aqueous fluid: water, electrolytes.
glycoproteins (mucin)
enzymes
natural antimicrobials- maintain good health in mouth

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

where does the digestion process begin?

A

enzymes in saliva in mouth to begin digestion- amylases

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

pH of saliva?

A

fairly neutral in mouth but does have some buffer capacity

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

3 roles of the oral cavity?

A
  • mastication
  • taste
  • deglutition
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

conditions treated by oro-buccal administration for local effect

A 
Dry mouth 
Infection
Irritation
Pain
Ulceration
...
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

what 3 things must be considered in terms of oro-buccal formulation?

A
  • Contact with the site of action
  • Residence time
  • Organoleptic properties:
    Sugar content and Acidity .
    both can affect buccal/dental health
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

what are the three types of lozenges?

A

hard
soft
chewable

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

moisture content and sugar content of hard lozenges?

A

low moisture content of 0.5-1.5%

potentially high sugar: 55-65% sucrose

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

how are hard lozenges prepared?

A

at high temperature

theyre similar to hard candy

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

composition of chewable lozenges? 4

A
  • glycerin and gelatin
  • API
  • colour
  • flavour
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

use of chewable lozenges

A

paediatric use

-caution may be perceived as candy

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

not all lozenges are drug free.

give an example of a P lozenge

A

Flurbiprofen: NSAID and, similar to others drugs in that class, can be irritant to the oral mucosae.
The ‘how to take instructions’ include a recommendation to move the lozenge around in the mouth to avoid prolong contact.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

Role of products for mouth ulcers (4)

A

alleviate discomfort associated with these lesions

reduce inflammation

provide pain relied- local anaethetic

/ speed up healing

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

how can mouth ulcer treatment be used to prevent infections?

A

by providing a barrier or through the inclusion of antiseptics.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

4 products for mouth ulcers

A

Mouthwash: saline/antiseptic
Gels
Sprays
Soft lozenges

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

what can cause dry mouth (xerostomia)? (3)

A
  • ADR to drugs
  • medical conditions
  • other causes: smoking, mouth breathing, stress…
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

3 examples of drugs that cause dry mouth?

A

anticholinergic drugs
diuretics
cancer chemo- or radiotherapy

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

3 medical conditions that cause dry mouth?

A

Sjögren syndrome (Links to an external site.)
nerve damage
dehydration
…

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
Q

complications of dry mouth?

and hows it treated?

A

increased risk of dental and periodontal conditions,

treated by addressing the underlying cause or using measures that help increase salivation/ artifical saliva substitutes

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
26
Q

Artificial saliva substitutes are available as? (4)

what do formulations include? (3)

A

lozenges, gels, sprays and soft lozenges.

Formulations can include saliva enzymes, mucin or electrolytes.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
27
Q

3 example products used as treatment for infections- affecting diff parts of oropharyngeal region.

A

hydrogen peroxide

chlorhexidine

antifungals

  • nystatin suspension
  • miconazole gel
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
28
Q

how are cold sores treated in patients not immunocompromised?

A

with a topical treatment:

Creams
- antiviral (e.g. aciclovir)
- disinfectants
Patches
- non-medicated, help with
wound healing
provide a barrier effect
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
29
Q

what 3 sites can drugs released from systemic oro-buccal dosage forms be absorbed from?

A
  • sublingual compartment
  • buccal mucosa
  • labial mucosa. lining of the lips
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
30
Q

4 benefits of Systemic oro-buccal dosage forms?

A
  • quick onset of action
  • easy adminstration
  • patient adherence
  • neutral environment in oral cavity (lower metabolic activity, neutral pH)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
31
Q

why do Systemic oro-buccal dosage forms provide quick onset of action?

A

directly absorbed into blood circulation, no first pass metabolism

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
32
Q

why is patient adherence increased with Systemic oro-buccal dosage forms?

A

Possibility for sustained release and decrease frequency of administration (mucoadhesive dosage forms)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
33
Q

5 disadvantages of systemic oro-buccal dosage forms

A
  • unsuitable for irritant drugs- damage to mouth mucosa
  • limit to dose administered
  • require adequate use by patient
  • Difficulties in dose splitting for some products
  • Impact of saliva
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
34
Q

how does saliva negatively impact use of systemic oro-buccal

A

oral cavity is a low fluid environment

drug wash-out into the saliva

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
35
Q

why is there a Limit to dose that can be administered with systemic oro-buccal

A

Limit to dose that can be administered vs. size of dosage form and patient comfort
- remember the patient might have to keep the dosage form in their mouth for a while!

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
36
Q

3 types of barriers to drug absorption?

A

physiological barriers
physico-chemical barriers
formulation barriers

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
37
Q

how is the small intestine

a) beneficial
b) limiting?

A

a) largest SA for absorption

b) enzymatic activity and the risk of first pass metabolism can be problematic for some drugs.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
38
Q

how is drug absorption impacted in mouth?

A

the fluid volume is small, but there is also a quick turnover of the saliva and this can have an impact on drug absorption.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
39
Q

order these in terms of enzymatic activity:

buccal
stomach
small I
large I
rectum
A

stomach and SI
large I and buccal
rectum

highest to lowest

40
Q

order these in terms of pH:

buccal
stomach
small I
large I
rectum
A

smallest to highest

stomach
small I
large I
rectum and buccal

41
Q

order these in terms of fluid volume:

buccal
stomach
small I
large I
rectum
A

buccal
stomach
large I
small I

rectum none

42
Q

order these in terms of surface area:

buccal
stomach
small I
large I
rectum
A 
buccal
rectum
stomach
large I
...
small I
43
Q

what are the 3 main types of mucosa in oral cavity?

A

Masticatory
Lining
Specialised

44
Q

what is the role of each type of mucosae in oral cavity

A

masticatory: mechanics of chewing. heavily keratinised
lining: non-keratinised. oro-mucosal drug absorption
specialised: taste buds to detect true taste

45
Q

where is each type of mucosae in oral cavity found?

A

mastciatory: hard palate and gums
lining: lips,cheeks, sublingual area, soft palate
specialised: tongue

46
Q

why is lining mucosamost suited to oro-mucosal drug absorption?

A

low levels of keratinisation.

47
Q

what three parameters (physico-chemical properties) are important in absorption in oral cavity?

A

Ionisation state: at buccal pH 6.2-7.4

Log P: balance between lipophilicity and hydrophilicity

Molecular weight

48
Q

why may oro-mucosal formulation be preferred?

A

preferred to maximise the bioavailability of a drug that is subject to extensive first-pass metabolism

49
Q

6 Examples of drug formulated for oro-mucosal administration

A

Drug name Molecular weight (Da) log P

Midazolam 325.8 4.3

Prochlorperazine 373.9 4.9

Fentanyl 528.6 2.3

GTN 227 1.6

Buprenorphine 467.6 4.98

Nicotine 162.2 1.17

50
Q

2 types of drug transport through oral mucosa

A

transcellular

paracellular

51
Q

how do transcellular and paracellular pathways differ?

A

trans: drug crosses cell membrane and travels THROUGH CELL
para: drug moves/ diffuses IN BETWEEN cells

52
Q

what is paracellular pathway of drug absorption through oral mucosa suitable for?

A

fairly hydrophilic and small drug molecules. fit in between intracellular space

53
Q

how can drug absorption be enhanced in paracellular pathway?

A

use of permeation enhancers: create more space between cells for bigger molecules to diffuse/travel through

54
Q

what does drug absorption depend on?

A

the oro-buccal dosage form and drug released

55
Q

where is drug absorbed from oro-buccal?

A
  • mouth and avoid first pass metab
  • mix with saliva and swallowed. go through GI tract and intestinal mucosa. subject to first pass metab and stability issues- degradation at low pH
56
Q

what type of kinetic profile would you get for drugs which fraction absorbed in intestine also bioavailable?

A

2 peak: biphasic.
[blood]/time graph

1st peak: fraction absorbed in mouth,
2nd peak: SI. may be lower depending on how extensively metab. later on as time to travel through GI

57
Q

how may drug given in this route be inactivated?

A

mix with saliva and be swallowed

This can lead to inactivation of the drug

58
Q

what will drug activity and second peak in plasma conc vx time curve depend on? absorption

A

properties of the drug and its bioavailability when going through the GIT

59
Q

what can Dosage forms be designed to provide

A

Immediate drug release
Controlled drug release

always: goal = deliver drug in a bioavailable form.

60
Q

3 Formulation considerations

A

contact
residence time
disintegration

61
Q

why are we concerned about Contact of formulation?

A

Is the drug in direct contact with its site of absorption in the oral cavity?

62
Q

why are we concerned about residence time of formulation?

A

How long is the drug in direct contact with its site of absorption in the oral cavity?

63
Q

why are we concerned about disintegration of formulation?

A

how quickly dosage form disintegrates to release the drug
- depend on the proposed use of the dosage form:
immediate vs controlled release

64
Q

how are oro-mucosal preparations Similar to other dosage forms? formulation considerations

A

will need to meet BP requirements

65
Q

what is the requirement of oro-buccal solution?

example?

A

must stay in contact with the lining mucosa (e.g. cheek) and is administered using the applicator provided

midazolam

66
Q

Oro-mucosal dosage forms: example II
Medicated chewing gum

3 benefits

A

Oral care
No water required
Stress relief

67
Q

Oro-mucosal dosage forms: example II
Medicated chewing gum

4 limitations and example

A

Organoleptics properties
Variable release
Production costs
Similar issues as non-medicated gum

Example: nicotine

68
Q

why is no liquid intake required with dosage form iii: Oro-dispersible formulations?

A

Quick dissolution

but some formulations not meant for oro-mucosal absorption = expected to swallow the drug after the film or tablet has dissolved

69
Q

6 advantages of Oro-dispersible formulations

A
  • Convenience
  • Immediate release
  • Easyadministration
  • Can be suitable for patient with difficulty swallowing
  • Less obtrusive than buccal tablets
  • Improved bioavailability
70
Q

oro-dispersible forms have improved bioavailability provided what?

A

provided buccal absorption is maximised (i.e. contact with site of action)

71
Q

4 disadvantages of oro-dispersible formulations?

A
  • Difficult to split dose
  • Very hygroscopic: handle with care
  • Organoleptic properties to consider
  • A fraction of the drug may be swallowed
72
Q

2 examples of oro-dispersible forms and how different?

A

nicotine and ondansetron films

one applied to roof of mouth, one to tip of tongue.
both allowed to fully dissolve

73
Q

Oro-mucosal dosage forms: example IV

Compressed lozenges how are they produced?

A

Produced through compression of a powder blend and very different to hard lozenges (local action)

74
Q

2 properties of compressed lozenges

A

high mechanical strength and low porosity.

75
Q

common excipient in Compressed lozenges and how administered?

A

Often formulated using dextrates as diluent and without disintegrant.

NOT chewed or swallowed whole.
associated with high inter- and intra-individual variability.

Examples: fentanyl, nicotine

76
Q

most common materials used for mucoadhesion

A

polymers (long chains of repeating units).

anionic/cationic/ neutral

77
Q

in terms of mucoadhesion, how will CATIONIC material work?

A

through electrostatic interactions with the negatively-charged mucus layer

78
Q

in terms of mucoadhesion, how will ANIONIC and NEUTRAL material work?

A

through hydrophobic and/or hydrogen bond formation

79
Q

ideal properties of mucoadhesive material ? (6)

A
  • biocompatible: non-toxic, non-irritant
  • form strong bonds
  • produce quick adhesion
  • have no incompatibilities
  • have good stability
  • be cost-effective
80
Q

Mucoadhesive tablets

Advantages (3)

A
  • slow dissolution
  • improved contact with site of absorption
  • increased residence time
81
Q

Mucoadhesive tablets

Disadvantages (3)

A
  • Discomfort
  • Can be irritant
  • Can detach from mucosa: risk if then adheres to a different mucosal surface
82
Q

Buccal tablets can be…

A

Buccal tablets can be uni- or multidirectional.

83
Q

how do uni and multidirectional buccal tablets difefr?

A

uni: drug released in one direction, to oral cavity only
multi: drug released anywhere from tablet. fraction absorbed in o.c, majority mixed with saliva and swallowed.

Example: prochlorperazine

84
Q

what happens after drug release and absorption of multidirectional tabs?

A

depending on drug properties and stability.

degradation in GI tract and first pass metab extensiveness- decides if 2nd absorption peak/not

85
Q

what is added to unidirectional tabs to ensure drug released in one direction and implication?

A

coated polymer = ensures max absorption in oral cavity thus bioavailability

not released in mouth and swallowed in saliva

86
Q 
Sublingual administration (under tongue)
Advantages
A
  • Rapid onset of action
  • Easy administration
  • Extensive drug absorption
  • Thin lining mucosa
  • Can be used in emergencies
  • Fast dissolution of dosage form
  • No need for water intake
87
Q 
Sublingual administration (under tongue)
Disadvantages
A
  • hard to use in unconscious patients
  • Smoking may reduce drug absorption
  • Size limit to ensure patient comfort
88
Q

why may sublingual administration not be used for sustained drug release?

A

Can interfere with eating/drinking.

89
Q

examples of sublingual formulation

and examples of drugs

A

spray
oil solution
- peppermint/ coconut

Examples: glyceryl trinitrate, nicotine and prochlorperazine

90
Q

Why is the hard palate less suitable for oro-buccal drug absorption?

A

The hard palate is heavily keratinised.

91
Q

What is the main source of fluid in the oral cavity? What roles do it play?

A

Saliva is the main source of fluid

92
Q

What type of non-specific interactions are involved in mucoadhesion? (3)

A

Electrostatic
Hydrophobic
Hydrogen bonding

93
Q

What drug properties are important for oro-buccal absorption?

A

Molecular weight, log P and ionisation state

94
Q

What makes fentanyl a suitable candidate for oro-mucosal administration?

logP: 2.3
MW: 529Da
Low oral bioav.

A

consider how likely the drug is to mix with saliva and be swallowed = biggest impact on final bioavailability. SmPC

Want good balance between unionised:ionised fraction (LogP) lipophilic enough to pass but soluble enough to dissolve (must be in solution to dissolve). Good for Oro-mucosal

95
Q

what has lowest bioavailability?
Buccal tabs
Sublingual
Lozenges

A
  • Lowest BA: compressed lozenges.
  • release fentanyl in all directions, some may be swallowed, = lower the overall bioavailability.
  • likely to be some intra-
    and inter-patient variability as well, depending on technique
  • Possible to have 2 peaks- one for absorption in the mouth and a delayed response from absorption in the intestine.
96
Q

whats the impact of swallowing the fentanyl tabs/ lozenges whole on tmax and cmax?

A

Fentanyl subject to extensive hepatic and intestinal first-pass elimination.
Swallowing Effentora/Actiq would:
- increase tmax (will take longer to reach peak plasma concentration)
- decrease Cmax (peak will be lower as limited bioavailability).

Lab 2 (12 decks)

Brainscape helps you reach your goals faster, through stronger study habits.
© 2024 Bold Learning Solutions. Terms and Conditions